Equibles does not estimate personal net worth.
Get an email with a short summary when Quest Diagnostics Inc publishes a filing, an earnings call transcript or a press release.
Get DGX alertsSam A. Samad is recorded as CFO at Quest Diagnostics Inc (DGX). The proxy statement of Quest Diagnostics Inc reports total compensation of $4,427,141 for Sam A. Samad in fiscal 2025, including a base salary of $693,269. Disclosed compensation is on record for 4 fiscal years. Sam A. Samad has spoken on 1 earnings call across 1 company, most recently for Quest Diagnostics Inc on October 22, 2026. Quest Diagnostics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Quest Diagnostics Inc includes Mr. Davis (CEO), Michael E. Prevoznik (General Counsel), Denise M. Morrison (Board Member) and 7 others.
“As Jim shared, we delivered a strong third quarter with consolidated revenues of $3.1 billion, up 10% versus the prior year. Revenues for diagnostic information services were up 10.2% compared to the prior year and 10.1% organically, reflecting continued strong growth in our physician, hospital, and consumer channels.”
Diagnostics & Research · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Quest Diagnostics Inc (DGX) | Executive Vice President and Chief Financial Officer | $693,269 | $4,427,141 |
| 2024 | Quest Diagnostics Inc (DGX) | Executive Vice President and Chief Financial Officer | $668,269 | $4,068,464 |
| 2023 | Quest Diagnostics Inc (DGX) | Executive Vice President and Chief Financial Officer | $650,000 | $3,975,114 |
| 2022 | Quest Diagnostics Inc (DGX) | Executive Vice President and Chief Financial Officer | $300,000 | $6,268,982 |
